AVADEL PHARMACEUTICALS PLC — Director's Dealing 2020

Aug 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2020-08-07

Reporting Person: McCamish Mark Anthony (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-07	Stock Option (Right to Buy)	$8.48	A	42000	Acquired	2020-08-07	ADSs (42000)	Direct

Footnotes

F1: Options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date.

F2: The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by AmericanDepositary Receipts.